Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Spectrum of pediatric kidney tumours with special references to WT1 immunostain at a tertiary care hospital

View through CrossRef
Context or Background: Pediatric renal tumours are the second most common solid tumours in children. The most common in this group is Wilms tumour with mesoblastic nephroma being the 2nd most common tumour in children, younger than 3 months. Aims and Objectives: The present study was conducted to study the epidemiological occurrence of pediatric renal tumours at a tertiary care hospital and to study the diagnostic efficacy of WT1 immunostaining in distinguishing Wilms tumour from other types of renal tumours. Materials and Methods: It was a single institution-based prospective and observational study conducted for 2 years (from October 2013 to September 2015) in the department of pathology in our hospital. A total of 50 cases were enrolled in this study all were below 15 years of age. Results: Nephroblastoma or Wilms tumour was found to be the most common type, occurring in 66% cases. Fourteen out of 33 cases of Wilms tumour showed triphasic components (blastemal, epithelial, and stromal) with Blastemal type Wilms being the second most common (11 cases). WT1 immunostaining was positive in 93.9% cases of nephroblastoma. The highest amount of nuclear positivity noted in blastemal cells followed by epithelial cells. Rhabdomyoblastic differentiation and regressive variant showed nonspecific cytoplasmic staining. Cystic partially differentiated nephroblastoma and diffuse anaplasia type Wilms tumour showed nuclear staining in blastemal cells. Conclusion: The expression of WT1 immunostain was found to be diagnostically significant in differentiating Wilms tumour from other renal tumours.
Title: Spectrum of pediatric kidney tumours with special references to WT1 immunostain at a tertiary care hospital
Description:
Context or Background: Pediatric renal tumours are the second most common solid tumours in children.
The most common in this group is Wilms tumour with mesoblastic nephroma being the 2nd most common tumour in children, younger than 3 months.
Aims and Objectives: The present study was conducted to study the epidemiological occurrence of pediatric renal tumours at a tertiary care hospital and to study the diagnostic efficacy of WT1 immunostaining in distinguishing Wilms tumour from other types of renal tumours.
Materials and Methods: It was a single institution-based prospective and observational study conducted for 2 years (from October 2013 to September 2015) in the department of pathology in our hospital.
A total of 50 cases were enrolled in this study all were below 15 years of age.
Results: Nephroblastoma or Wilms tumour was found to be the most common type, occurring in 66% cases.
Fourteen out of 33 cases of Wilms tumour showed triphasic components (blastemal, epithelial, and stromal) with Blastemal type Wilms being the second most common (11 cases).
WT1 immunostaining was positive in 93.
9% cases of nephroblastoma.
The highest amount of nuclear positivity noted in blastemal cells followed by epithelial cells.
Rhabdomyoblastic differentiation and regressive variant showed nonspecific cytoplasmic staining.
Cystic partially differentiated nephroblastoma and diffuse anaplasia type Wilms tumour showed nuclear staining in blastemal cells.
Conclusion: The expression of WT1 immunostain was found to be diagnostically significant in differentiating Wilms tumour from other renal tumours.

Related Results

Anti-apoptotic function of T-KTS+, T-KTS-, WT1+/+ and WT1+/- isoforms in breast cancer
Anti-apoptotic function of T-KTS+, T-KTS-, WT1+/+ and WT1+/- isoforms in breast cancer
Abstract Background: WT1 was originally identified in Wilms tumor, a childhood kidney cancer. This gene was expressed in wide variety of solid cancers. Alternative ...
Abstract 1237: WT1, Wnt signaling and E-cadherin in prostate cancer
Abstract 1237: WT1, Wnt signaling and E-cadherin in prostate cancer
Abstract Prostate carcinoma is the most common malignancy and second leading cause of death among American men. The molecular mechanisms that control the progression...
The Wilms' tumor suppressor WT1 regulates Interleukin‐10 expression in macrophagocytic cells
The Wilms' tumor suppressor WT1 regulates Interleukin‐10 expression in macrophagocytic cells
The Wilms' tumor gene, WT1, encodes a zinc finger transcription factor which functions both as a tumor suppressor and a key regulator of embryonic development. WT1 is also expresse...

Back to Top